rs121434463
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
Variant has been reported in ClinVar as Uncertain significance (★★★).
Frequency
Consequence
missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRNL2 | unassigned_transcript_4814 | c.55A>G | p.Asn19Asp | missense_variant | Exon 1 of 1 | |||
ND5 | unassigned_transcript_4815 | c.-17A>G | upstream_gene_variant | |||||
ND4 | unassigned_transcript_4811 | c.*183A>G | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD4 exome Cov.: 0
Mitomap
ClinVar
Submissions by phenotype
Inborn mitochondrial myopathy Pathogenic:1
- -
Mitochondrial disease Uncertain:1
The m.12320A>G variant in MT-TL2 has been reported in one individual with primary mitochondrial disease to date (PMID: 9012410), in a woman with progressive myopathy, acidosis, ptosis, and ragged red and COX-negative fibers on muscle biopsy. The variant was present at 70% heteroplasmy in muscle on first biopsy and was found to be present at 90% on subsequent biopsy, coinciding with a 12-year progression in symptoms. There is no report of her family members being testing and there are no additional reports of large families with this variant segregating with disease. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). Computational predictors are conflicting (MitoTIP: 37.3%; HmtVAR: 0.7). Single fiber testing showed higher levels of the variant in COX-negative fibers (88-96%) compared to COX positive fibers (60-88%; PMID: 9450773; PS3_supporting). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on April 22, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM2_supporting, PS3_supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at